Fabrizio Tabbo
8PUBLICATIONS
124CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Oct 09, 2024
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors.Ferdinandos Skoulidis, Haniel A Araujo, Minh Truong Do
|Jul 27, 2024
Clinical and Molecular Traits of a Novel SPECC1L-ALK Fusion in a Patient with Advanced Non-Small Cell Lung Cancer.Antonella Centonza, Tommaso Mazza, Domenico Trombetta
|Jun 28, 2023
Targeting CCR7-PI3Kγ overcomes resistance to tyrosine kinase inhibitors in ALK-rearranged lymphoma.Cristina Mastini, Marco Campisi, Enrico Patrucco
|Jun 07, 2023
Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer.Dario P Anobile, Iris C Salaroglio, Fabrizio Tabbò
|Sep 27, 2022
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells.Ramona Rotolo, Valeria Leuci, Chiara Donini
|Jun 02, 2021
Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations.Paolo Bironzo, Maria Lucia Reale, Tessa Sperone
Pageof 2
Frequent Collaborators
5 joint publications
Giorgio Vittorio Scagliotti
3 joint publications
Luisella Righi
2 joint publications
Francesca Napoli
2 joint publications
Ferdinandos Skoulidis
2 joint publications
Paolo Bironzo
2 joint publications
Emilio Hirsch
2 joint publications
John V Heymach
2 joint publications
Federica Benso
2 joint publications
Iris Chiara Salaroglio
2 joint publications
Silvia Novello
